Optic nerve and optic radiation neurodegeneration in patients with glaucoma: In vivo analysis with 3-T diffusion-tensor MR imaging

Radiology

Volumn 252, Issue 2, 2009, Pages 496-501

  Garaci, Francesco G ^a,b   Bolacchi, Francesca ^a   Cerulli, Angelica ^a,c   Melis, Milena ^a   Spanò, Arnoldo ^a   Cedrone, Claudio ^a   Floris, Roberto ^a   Simonetti, Giovanni ^a   Nucci, Carlo ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b IRCCS San Raffael   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; FEMALE; GLAUCOMA; HUMAN; IMAGING SYSTEM; MALE; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; DIFFUSION WEIGHTED IMAGING; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SENSORY NERVE;

AFFERENT PATHWAYS; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; OPTIC NERVE; OPTIC NERVE DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70249141259     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2522081240     Document Type: Article

References (29)

1. Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 2008;86(1):63-70.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90(3):262-267.
3. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004;363(9422):1711-1720.
4. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). VII. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130(4):429-440.
5. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120(10):1268-1279. (Pubitemid 36105431)
6. Gupta N, Yücel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol 2007;18(2):110-114.
7. Gupta N, Yücel YH. What changes can we expect in the brain of glaucoma patients? Surv Ophthalmol 2007;52(6 suppl 1):S122-S126.
8. Yücel YH, Zhang Q, Gupta N, Kaufman PL, Weinreb RN. Loss of neurons in magnocellular and parvocellular layers of the LGN in glaucoma. Arch Ophthalmol 2000;118(3):378-384.
9. Gupta N, Ang LC, Noel de Tilly L, Bidaisee L, Yücel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006;90(6):674-678. (Pubitemid 43835477)
10. Trip SA, Wheeler-Kingshott C, Jones SJ, et al. Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage 2006;30(2):498-505.
11. Hui ES, Fu QL, So KF, Wu EX. Diffusion tensor MR study of optic nerve degeneration in glaucoma. Conf Proc IEEE Eng Med Biol Soc 2007;2007:4312-4315.
12. Katz J, Sommer A. Reliability indexes of automated perimetric tests. Arch Ophthalmol 1988;106(9):1252-1254. (Pubitemid 18216844)
13. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St. Louis, Mo: Mosby, 1993.
14. Mori S, Crain BJ, Chacko VP, van Zijl PC. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999;45(2):265-269. (Pubitemid 29072377)
15. Yamamoto A, Miki Y, Urayama S, et al. Diffusion tensor fiber tractography of the optic radiation: analysis with 6-, 12-, 40-, and 81-directional motion probing gradients - a preliminary study. AJNR Am J Neuroradiol 2007;28(1):92-96. (Pubitemid 46147542)
16. Wheeler-Kingshott CA, Trip SA, Symms MR, Parker GJ, Barker GJ, Miller DH. In vivo diffusion tensor imaging of the human optic nerve: pilot study in normal controls. Magn Reson Med 2006;56(2):446-451.
17. Khong PL, Zhou LJ, Cheng OG, Chung B, Cheung RT, Wong V. The evaluation of wallerian degeneration in chronic paediatric middle cerebral artery infarction using diffusion tensor MR imaging. Cerebrovasc Dis 2004;18(2-3):240-247. (Pubitemid 39279401)
18. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS). I. Study design and methods and baseline characteristics of study patients. Control Clin Trials 1994;15(4):299-325.
19. The CNTGSC Investigators. Collaborative Normal-Tension Glaucoma Study Group: comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126(4):487-497.
20. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 1999;117(5):573-583.
21. Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 1999;106(4):653-662.
22. Leske MC, Heijl A, Hyman L, Bengtsson B. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999;106(11):2144-2153. (Pubitemid 30194238)
23. The Canadian Glaucoma Study Group. Canadian Glaucoma Study. I. Study design, baseline characteristics, and preliminary analyses. Can J Ophthalmol 2006;41(5):566-575.
24. Harwerth RS, Carter-Dawson L, Shen F. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci 1999;40(10):2242-2250. (Pubitemid 29418378)
25. Garway-Heath DF, Caprioli J, Fitzke FW, Hitchings RA. Scaling the hill of vision: the physiological relationship between light sensitivity and ganglion cell numbers. Invest Ophthalmol Vis Sci 2000;41(7):1774-1782. (Pubitemid 30354349)
26. Swanson WH, Felius J, Pan F. Perimetric defects and ganglion cell damage: interpreting linear relations using a two-stage neural model. Invest Ophthalmol Vis Sci 2004;45(2):466-472. (Pubitemid 38140502)
27. Garway-Heath DF, Holder GE, Fitzke FW, Hitchings RA. Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma. Invest Ophthalmol Vis Sci 2002;43(7):2213-2220.
28. Harwerth RS, Carter-Dawson L, Smith EL 3rd, Barnes G, Holt WF, Crawford ML. Neural losses correlated with visual losses in clinical perimetry. Invest Ophthalmol Vis Sci 2004;45(9):3152-3160.
29. Harwerth RS, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol 2006;124(6):853-859.